Related Experiment Video
Updated: Jun 28, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
HSP90α-USP7-DNMT1 axis drives HCC recurrence after microwave ablation by disrupting ACSS3-mediated propionate
Ye Chen1, Jiaxin Bei2, Xinkun Huang1
1Department of Minimally Invasive Interventional Radiology and Department of Radiology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China; Guangdong Engineering Technology Research Center of Interventional Oncology and Precision Drug Delivery, Guangzhou 510260, China.
Abstract:
Insufficient microwave ablation (iMWA) of hepatocellular carcinoma (HCC) often leads to rapid and aggressive recurrence, and effective intervention remains a formidable challenge. Here, we show that the DNA methylation machinery is aberrantly activated in residual HCC following iMWA. The heat-responsive stress protein HSP90α collaborates with the deubiquitinase USP7 to stabilize and upregulate DNA methyltransferase DNMT1, thereby transducing the sublethal heat-stress input from iMWA into an epigenetic output and elevating DNA methylation levels. Sublethal heat-stress-induced DNMT1 upregulation significantly promotes the growth and invasive potential of post-iMWA residual HCC cells, a process that involves disruption of propionate metabolism. Mechanistically, the propionate-metabolizing enzyme ACSS3 in residual HCC is found to be silenced by DNMT1-mediated promoter hypermethylation, impairing propionate-to-propionyl-coenzyme A (CoA) conversion. Reduction in propionyl-CoA production enhances the activity of the fatty acid β-oxidation (FAO) rate-limiting enzyme carnitine palmitoyltransferase 1 (CPT1), ultimately stimulating FAO-dependent ATP regeneration. Critically, we developed a liposomal CRISPR-dCas9-based locus-specific demethylation system for precise epigenetic reactivation of ACSS3 and demonstrated its ability to effectively prevent post-iMWA HCC recurrence and metastasis, with more pronounced efficacy when combined with propionate supplementation. Our findings identify a novel DNMT1-driven "epigenetic-metabolic cascade" as a central mechanism promoting HCC recurrence following iMWA, emphasizing the therapeutic potential of ACSS3-targeted methylation editing.
Insights
Insufficient microwave ablation for liver cancer (HCC) triggers DNA changes that promote recurrence. Targeting these epigenetic and metabolic shifts with gene editing and propionate supplementation offers a new strategy to prevent cancer regrowth.
Area of Science:
- Oncology
- Epigenetics
- Metabolic Regulation
Background:
- Hepatocellular carcinoma (HCC) recurrence after insufficient microwave ablation (iMWA) is a significant clinical challenge.
- Sublethal heat stress from iMWA activates aberrant cellular mechanisms promoting residual tumor growth and invasion.
Purpose of the Study:
- To elucidate the epigenetic and metabolic alterations driving HCC recurrence post-iMWA.
- To investigate the role of DNA methyltransferase 1 (DNMT1) in mediating these changes.
- To develop and evaluate a novel epigenetic therapy targeting ACSS3 for preventing HCC recurrence.
Main Methods:
- Analysis of DNA methylation machinery and heat-shock protein interactions in residual HCC.
- Investigated the impact of DNMT1 upregulation on propionate metabolism and fatty acid oxidation (FAO).
- Developed and tested a liposomal CRISPR/dCas9 system for locus-specific ACSS3 demethylation in a preclinical setting.
Main Results:
- Sublethal heat stress activates HSP90α/USP7/DNMT1 axis, increasing DNA methylation in residual HCC.
- DNMT1-mediated silencing of ACSS3 impairs propionate metabolism, enhancing FAO-dependent ATP production and tumor growth.
- CRISPR/dCas9-mediated ACSS3 reactivation, especially with propionate supplementation, effectively prevented HCC recurrence and metastasis.
Conclusions:
- A novel DNMT1-driven epigenetic-metabolic cascade promotes HCC recurrence after iMWA.
- Targeting ACSS3 methylation editing represents a promising therapeutic strategy for liver cancer.
- Combination therapy with propionate supplementation enhances the efficacy of epigenetic interventions.
More Related Videos
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019